FDA Approves First Medical Device To Treat ADHD In Children

(CNN) — The first medical device to treat childhood attention deficit hyperactivity disorder, or ADHD, was OK’d Friday by the US Food and Drug Administration. Designated for children ages 7 to 12 who are not currently on medication for the disorder, the device delivers a low-level electrical pulse to the parts of the brain responsible for ADHD symptoms. “This new device offers a safe, non-drug option for treatment of ADHD in pediatric patients through the use of mild nerve stimulation, a first of its kind,” Carlos Peña, director of the Division of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health, said in a statement. Called the Monarch external Trigeminal Nerve Stimulation System, eTNS,and marketed by NeuroSigma, the treatment is only available by prescription and must be monitored by a caregiver. The pocket-sized device is connected by wire to a small adhesive patch placed on the child’s forehead above the eyebrows. Designed to be used at home while sleeping, it delivers a “tingling” electrical stimulation to branches of the cranial nerve that delivers sensations from the face to the brain. A clinical trial of 62 children showed that the eTNS increases activity in the regions of the brain that regulate attention, emotion and behavior, all key components of ADHD. Compared to a placebo, children using the device had statistically significant improvement in their ADHD sympto...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News CNN ADHD Source Type: news

Related Links:

Publication date: Available online 9 July 2020Source: Preventive MedicineAuthor(s): Elizabeth M. Saewyc, Gu Li, Amy L. Gower, Ryan J. Watson, Darin Erickson, Heather L. Corliss, Marla E. Eisenberg
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
BACKGROUND: There is a lack of data from low- and middle-income countries on whether anxiety independently predicts a more chronic course for depression. Methods: We undertook secondary data analysis of a cluster randomised controlled trial in Zimbabwe...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news
This study examined the relationship between different aspects of physical ill-health and the risk of sui...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
OBJECTIVE: The primary goal was to analyze the level and trend of the burden of suicide mortality in Mexico between 1990 and 2017 at a national and state scale. METHODS: A secondary analysis based on the 2017 global burden of disease study. Mortality r...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Police violence during protests occurs worldwide with varying levels ranging from physical abuse to lethal use of force. Although prior research has investigated the health consequences of exposure to police violence (EPV), EPV's relationship with proteste...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts. Prominent and expensive failures in Alzheimer’s disease therapies have led to a contagious belief system in some parts of the biopharma industry that neuroscience is just too hard, too risky, and too uncertain. But, might this belief system itself be a residual bias of the past? Close inspection reveals all the signs...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Commentary Current Issue Source Type: research
Publication date: Available online 26 October 2017 Source:Epilepsy & Behavior Author(s): Andres M. Kanner, Helen Scharfman, Nathalie Jette, Evdokia Anagnostou, Christophe Bernard, Carol Camfield, Peter Camfield, Karen Legg, Ilan Dinstein, Peter Giacobe, Alon Friedman, Bernd Pohlmann-Eden Epilepsy is a neurologic condition which often occurs with other neurologic and psychiatric disorders. The relation between epilepsy and these conditions is complex. Some population-based studies have identified a bidirectional relation, whereby not only patients with epilepsy are at increased risk of suffering from some of these neur...
Source: Epilepsy and Behavior - Category: Neurology Source Type: research
iev G Abstract The neuroimmune system represents a dense network of biochemical signals associated with neurotransmitters, neuropeptides, neurohormones, cytokines, chemokines, and growth factors synthesized in neurons, glial cells and immune cells, to maintain systemic homeostasis. Endogenous and/or exogenous, noxious stimuli in any tissue are captured by sensor cells to inform the brain; likewise, signals originating at the central nervous system (CNS) level are transmitted to peripheral immune effectors which react to central stimuli. This multidirectional information system makes it possible for the CNS to resp...
Source: Epilepsy Curr - Category: Neurology Authors: Tags: Curr Pharm Des Source Type: research
ConclusionsIn this large birth cohort, there were no significant associations between preschool eczema and medications for ADHD, depression/anxiety/phobia, migraine or epilepsy at school age.This article is protected by copyright. All rights reserved.
Source: Pediatric Allergy and Immunology - Category: Allergy & Immunology Authors: Tags: Original Source Type: research
Co-morbid conditions frequently occur in pediatric headaches and may significantly affect their management. Co-morbidities that have been associated with pediatric headaches include attention-deficit/hyperactivity disorder, autism, developmental disabilities, depression, anxiety, epilepsy, obesity, infantile colic, atopic disorders, inflammatory bowel disease and irritable bowel syndrome. The goal of this review is to elucidate common comorbidities associated with pediatric headache, thereby empowering child neurologists to identify common triggers and tailor management strategies that address headache and associated comorbidities.
Source: Seminars in Pediatric Neurology - Category: Neurology Authors: Source Type: research
More News: Adderall | ADHD | Amphetamine | Brain | Canada Health | Centers for Disease Control and Prevention (CDC) | Child Development | Children | Clinical Trials | Concerta | Depression | Epilepsy | Food and Drug Administration (FDA) | Headache | Health | Hyperactivity | Insulin | Insurance | Medical Devices | Methylphenidate | Migraine | Neurology | Pediatrics | Psychology | Ritalin | Sports Medicine | Statistics | Study | Vyvanse | Websites